PRIP Scheme opens its second call under the ₹5,000 crore initiative, inviting pharma and MedTech projects from startups, MSMEs and industry.
Read MoreMedTech innovation
Tata Elxsi Q4 FY26: Revenue at ₹993.8 Cr, PBT Margin Surges 10.7% QoQ
Tata Elxsi Q4 FY26 reports ₹993.8 Cr revenue, strong margin growth, strategic deals, and ₹75 dividend announcement.
Read More